COVID-19 ANNOUNCEMENT

SUANFARMA is fully committed to the well-being of our employees, the quality of the services we provide to our valuable clients and our contribution to the general health of all people.

As developers and manufacturers of life saving drugs, it is essential for us to keep our day-to-day activities even during this challenging health crisis. Moreover, we have identified solutions to increase our capacities to be able to help to other companies or health agencies with additional medicine supplies if required.

Continue reading

Suanfarma to acquire an API Manufacturing Facility in Italy

SUANFARMA Group, a leading company in the development, production and distribution of active pharmaceutical ingredients for human and animal health use, today announced it has entered into a binding contractual commitment for the intended purchase of Sandoz Industrial Products S.p.A, an API manufacturing facility in Rovereto, Italy, as part of a continuing expansion of its global footprint.

Continue reading